中國醫藥大學 |
2010-07-31 |
以生物資訊體學以及藥物資訊體學開發多靶點抗癌藥物
|
陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2010-02-28 |
DISCOVERY OF POTENT INHIBITORS FOR H5N1, H5N2, H5N7, AND H5N9 BY MOLECULAR DOCKING APPROACH AND VIRTUAL SCREENING FROM NCI DATABASE
|
陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2010-02-28 |
A NOVEL STRATEGY FOR DESIGNING THE TRIPLE-TARGET INHIBITORS FOR EGFR, HER2, AND HSP90 BY DOCKING, PHARMACOPHORE, AND 3D-QSAR
|
陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2010-01 |
Drug design for Influenza A virus subtype H1N1
|
陳建宇(Chien-Yu Chen); 黃泓縉(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-12 |
Weighted equation and rules – A novel concept for evaluating protein-ligand interaction
|
陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-12 |
Computational screening and design of traditional Chinese medicine (TCM) to block phosphodiesterase-5
|
陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-12 |
Magnolol encapsulated by different acyl chain length of liposomes on inhibiting proliferation of smooth muscle cells
|
陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10-22 |
[Invited section Chair] Computer Aided Drug Design and SAR Studies
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian); 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-10-22 |
[Invited section Chair] Computer Aided Drug Design and SAR Studies
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian); 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-10-22 |
[Invited section Chair] Computer Aided Drug Design and SAR Studies
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian); 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-10-20 |
Ligand-based design for heat shock protein 90 inhibitors
|
陳語謙(Chen, Calvin Yu-Chian); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-10-20 |
Ligand-based design for heat shock protein 90 inhibitors
|
陳語謙(Chen, Calvin Yu-Chian); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-10-20 |
Discovery the triple inhibitors of H5N1, H5N2, and H5N7 by pharmacophore analysis
|
(Chien-Yu Chen); 陳語謙(Chen, Calvin Yu-Chian)*; 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 包大?(Da-Tian Bau); 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-10-20 |
Discovery the triple inhibitors of H5N1, H5N2, and H5N7 by pharmacophore analysis
|
(Chien-Yu Chen); 陳語謙(Chen, Calvin Yu-Chian)*; 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 包大?(Da-Tian Bau); 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-10-17 |
A Novel Strategy for Designing Dual-target Inhibitors of KU86 and XRCC4
|
陳建宇(Chien-Yu Chen); 蔡輔仁(Fuu-Jen Tsai); 鍾景光(Jing-Gung Chung); 蔡長海(Chang-Hai Tsai); 徐媛曼(Yuan-Man Hsu); 黃泓縉(Hung-Jin Huang); 侯庭鏞(Tin-Yun Ho); (Yea-Huey Chang); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-10-17 |
Reducing without Side Effects? A Novel Strategy for Designing the PPAR Agonists
|
(Yea-Huey Chang); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10-17 |
Is That Possible to Design the Versatile Inhibitors for H1N1, H5N1, H5N2, and H5N7 ?
|
陳建宇(Chien-Yu Chen); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10-17 |
Could Traditional Chinese Medicine Used for Curing Erectile Dysfunction
|
陳建宇(Chien-Yu Chen); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10-17 |
Drug Design for KU86 in DNA Break Repair System
|
陳建宇(Chien-Yu Chen); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10-17 |
Dual-targeted Drug Design of HER2 and HSP90 by CoMFA Model and Pharmacophore Analysis
|
黃泓縉(Hung-Jin Huang); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10-17 |
Drug Design for AMP-Activated Protein Kinase Agonists in Silico
|
陳建宇(Chien-Yu Chen); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10-17 |
Drug Design for the Influenza A Virus Subtype H1N1
|
陳建宇(Chien-Yu Chen); 蔡輔仁(Fuu-Jen Tsai); 鍾景光(Jing-Gung Chung); 蔡長海(Chang-Hai Tsai); 徐媛曼(Yuan-Man Hsu); 黃泓縉(Hung-Jin Huang); 侯庭鏞(Tin-Yun Ho); (Yea-Huey Chang); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-10-17 |
Drug Design for XRCC4 in Silico
|
黃泓縉(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai); 鍾景光(Jing-Gung Chung); 蔡長海(Chang-Hai Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); (Yea-Huey Chang); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10-17 |
What is the Key Point for Designing HER2 Inhibitors
|
黃泓縉(Hung-Jin Huang); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10-09 |
Fabrication of multi-functional SiO2@Au core-shell nanoparticles
|
(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian); 陳語謙(Chen, Calvin Yu-Chian); 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-10-09 |
Fabrication of multi-functional SiO2@Au core-shell nanoparticles
|
(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian); 陳語謙(Chen, Calvin Yu-Chian); 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-10-09 |
Fabrication of multi-functional SiO2@Au core-shell nanoparticles
|
(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian); 陳語謙(Chen, Calvin Yu-Chian); 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-10-09 |
Discovery of the AMP-activated protein kinase agonists by molecular docking and 3D-QSAR analysis
|
陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)*; 陳建宇(Chien-Yu Chen); 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-10-09 |
Discovery of the AMP-activated protein kinase agonists by molecular docking and 3D-QSAR analysis
|
陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)*; 陳建宇(Chien-Yu Chen); 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-10 |
Fabrication of SiO2@Au Core-Shell Multi-functional Nanoparticles (MFNPs) for Imaging and Thermotherapy
|
(Yea-Huey Chang); 包大靝(Da-Tian Bau); 李英雄(Ying-shiung Lee); 陳建宇(Chien-Yu Chen); 黃泓縉(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
Study of AMP-activated Protein Kinase Agonists by Structure-based Drug Designing
|
(Yea-Huey Chang); 侯庭鏞(Tin-Yun Ho); 吳介信(Chieh-Hsi Wu); 陳建宇(Chien-Yu Chen); 黃泓溍(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
Discovery the inhibitors of H5N1, H5N2, and H5N7 by pharmacophore analysis
|
陳建宇(Chien-yu CHEN); (Yea-huey CHANG); 包大靝(Da-Tian Bau); 黃泓縉(Hung-jin HUANG); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
Is That Possible to Design the Versatile Inhibitors for H1N1, H5N1, H5N2, and H5N7
|
陳建宇(Chien-Yu Chen); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
Drug Design for the Influenza A Virus Subtype H1N1
|
陳建宇(Chien-Yu Chen); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
Drug Design for KU86 in DNA Break Repair System
|
陳建宇(Chien-Yu Chen); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
A Novel Strategy for Designing Dual-target Inhibitors of KU86 and XRCC4
|
陳建宇(Chien-Yu Chen); 蔡輔仁(Fuu-Jen Tsai); 鍾景光(Jing-Gung Chung); 蔡長海(Chang-Hai Tsai); 徐媛曼(Yuan-Man Hsu); 黃泓縉(Hung-Jin Huang); 侯庭鏞(Tin-Yun Ho); (Yea-Huey Chang); 包大靝(Da-Tian Bau)*; 蔡銘修(Ming-Hsui Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
Drug Design for AMP-Activated Protein Kinase Agonists in Silico
|
陳建宇(Chien-Yu Chen); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
Could Traditional Chinese Medicine Used for Curing Erectile Dysfunction
|
陳建宇(Chien-Yu Chen);包大靝(Da-Tian Bau);蔡銘修(Ming-Hsui Tsai);徐媛曼(Yuan-Man Hsu);侯庭鏞(Tin-Yun Ho);黃泓縉(Hung-Jin Huang);(Yea-Huey Chang);蔡輔仁(Fuu-Jen Tsai)*;蔡長海(Chang-Hai Tsai)*;陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
Ligand-Based Dual Target Drug Design for H1N1: Swine Flu- A Preliminary First Study
|
陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 包大靝(Da-Tian Bau); (Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
Drug design for Influenza A virus subtype H1N1
|
陳建宇(Chien-Yu Chen);包大靝(Da-Tian Bau);(Yea-Huey Chang);徐媛曼(Yuan-Man Hsu);侯庭鏞(Tin-Yun Ho);黃泓縉(Hung-Jin Huang);蔡輔仁(Fuu-Jen Tsai)*;蔡長海(Chang-Hai Tsai)*;陳語謙(Chen, Calvin Yu-Chian)*;(Yu-An Chang) |
中國醫藥大學 |
2009-10 |
Ligand-based design for heat shock protein 90 inhibitors
|
黃泓縉(Hung-Jin Huang); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
Drug Design for XRCC4 in Silico
|
黃泓縉(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai); 鍾景光(Jing-Gung Chung); 蔡長海(Chang-Hai Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); (Yea-Huey Chang); 包大靝(Da-Tian Bau)*; 蔡銘修(Ming-Hsui Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
Dual-targeted Drug Design of HER2 and HSP90 by CoMFA Model and Pharmacophore Analysis
|
黃泓縉(Hung-Jin Huang); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
Reducing without Side Effects? A Novel Strategy for Designing the PPAR Agonists
|
(Yea-Huey Chang); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); 黃泓縉(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
What is the Key Point for Designing HER2 Inhibitors
|
黃泓縉(Hung-Jin Huang); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
Ligand-based design for heat shock protein 90 inhibitors
|
陳建宇(Chien-yu CHEN);(Yea-huey CHANG);包大靝(Da-Tian Bau);黃泓縉(Hung-jin HUANG);蔡輔仁(Fuu-Jen Tsai)*;蔡長海(Chang-Hai Tsai)*;陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-10 |
Discovery the inhibitors of H5N1, H5N2, and H5N7 by pharmacophore analysis
|
陳建宇(Chien-yu CHEN); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
中國醫藥大學 |
2009-09-04 |
Application of Nano particles for cancer therapy
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-09-04 |
Application of Nano particles for cancer therapy
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian) |
中國醫藥大學 |
2009-09 |
Structure-based Drug Design of HSP 90 Inhibitors by Chen's Rules and Equation
|
陳語謙(Chen, Calvin Yu-Chian)*; (Guan-Wen Chen); (Winston Yu-Chen Chen) |